These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells. Kerkelä E; Laitinen A; Räbinä J; Valkonen S; Takatalo M; Larjo A; Veijola J; Lampinen M; Siljander P; Lehenkari P; Alfthan K; Laitinen S Stem Cells; 2016 Mar; 34(3):781-90. PubMed ID: 26731338 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation. Sattler C; Steinsdoerfer M; Offers M; Fischer E; Schierl R; Heseler K; Däubener W; Seissler J Cell Transplant; 2011; 20(8):1221-30. PubMed ID: 21176405 [TBL] [Abstract][Full Text] [Related]
4. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity. Häusler SF; Montalbán del Barrio I; Strohschein J; Chandran PA; Engel JB; Hönig A; Ossadnik M; Horn E; Fischer B; Krockenberger M; Heuer S; Seida AA; Junker M; Kneitz H; Kloor D; Klotz KN; Dietl J; Wischhusen J Cancer Immunol Immunother; 2011 Oct; 60(10):1405-18. PubMed ID: 21638125 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem/Stromal Cells Derived from Dental Tissues Mediate the Immunoregulation of T Cells through the Purinergic Pathway. Poblano-Pérez LI; Monroy-García A; Fragoso-González G; Mora-García ML; Castell-Rodríguez A; Mayani H; Álvarez-Pérez MA; Pérez-Tapia SM; Macías-Palacios Z; Vallejo-Castillo L; Montesinos JJ Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273524 [TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation. Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900 [TBL] [Abstract][Full Text] [Related]
7. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. Clayton A; Al-Taei S; Webber J; Mason MD; Tabi Z J Immunol; 2011 Jul; 187(2):676-83. PubMed ID: 21677139 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions. de Lourdes Mora-García M; García-Rocha R; Morales-Ramírez O; Montesinos JJ; Weiss-Steider B; Hernández-Montes J; Ávila-Ibarra LR; Don-López CA; Velasco-Velázquez MA; Gutiérrez-Serrano V; Monroy-García A J Transl Med; 2016 Oct; 14(1):302. PubMed ID: 27782859 [TBL] [Abstract][Full Text] [Related]
9. CD73 Pathway Contributes to the Immunosuppressive Ability of Mesenchymal Stem Cells in Intraocular Autoimmune Responses. Chen X; Shao H; Zhi Y; Xiao Q; Su C; Dong L; Liu X; Li X; Zhang X Stem Cells Dev; 2016 Feb; 25(4):337-46. PubMed ID: 26650818 [TBL] [Abstract][Full Text] [Related]
10. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Niemeyer P; Kornacker M; Mehlhorn A; Seckinger A; Vohrer J; Schmal H; Kasten P; Eckstein V; Südkamp NP; Krause U Tissue Eng; 2007 Jan; 13(1):111-21. PubMed ID: 17518585 [TBL] [Abstract][Full Text] [Related]
11. Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. Mandapathil M; Hilldorfer B; Szczepanski MJ; Czystowska M; Szajnik M; Ren J; Lang S; Jackson EK; Gorelik E; Whiteside TL J Biol Chem; 2010 Mar; 285(10):7176-86. PubMed ID: 19858205 [TBL] [Abstract][Full Text] [Related]
12. An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis. Chao YH; Wu HP; Wu KH; Tsai YG; Peng CT; Lin KC; Chao WR; Lee MS; Fu YC PLoS One; 2014; 9(10):e110338. PubMed ID: 25337817 [TBL] [Abstract][Full Text] [Related]
13. CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation. Morandi F; Horenstein AL; Chillemi A; Quarona V; Chiesa S; Imperatori A; Zanellato S; Mortara L; Gattorno M; Pistoia V; Malavasi F J Immunol; 2015 Aug; 195(3):965-72. PubMed ID: 26091716 [TBL] [Abstract][Full Text] [Related]
14. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes. Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528 [TBL] [Abstract][Full Text] [Related]
15. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Trivedi P; Hematti P Exp Hematol; 2008 Mar; 36(3):350-9. PubMed ID: 18179856 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. Ghannam S; Pène J; Moquet-Torcy G; Jorgensen C; Yssel H J Immunol; 2010 Jul; 185(1):302-12. PubMed ID: 20511548 [TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection. Jenabian MA; Seddiki N; Yatim A; Carriere M; Hulin A; Younas M; Ghadimi E; Kök A; Routy JP; Tremblay A; Sévigny J; Lelievre JD; Levy Y PLoS Pathog; 2013; 9(4):e1003319. PubMed ID: 23658513 [TBL] [Abstract][Full Text] [Related]
19. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells. Lee HJ; Kim SN; Jeon MS; Yi T; Song SU Sci Rep; 2017 Mar; 7():44486. PubMed ID: 28290526 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity. Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]